nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CYP2D6—Alzheimer's disease	0.368	1	CbGaD
Ciclesonide—CYP2D6—Rivastigmine—Alzheimer's disease	0.118	0.264	CbGbCtD
Ciclesonide—CYP2D6—Donepezil—Alzheimer's disease	0.0944	0.211	CbGbCtD
Ciclesonide—CYP3A4—Rivastigmine—Alzheimer's disease	0.0751	0.168	CbGbCtD
Ciclesonide—CYP2D6—Galantamine—Alzheimer's disease	0.0608	0.136	CbGbCtD
Ciclesonide—CYP3A4—Donepezil—Alzheimer's disease	0.06	0.134	CbGbCtD
Ciclesonide—CYP3A4—Galantamine—Alzheimer's disease	0.0387	0.0865	CbGbCtD
Ciclesonide—CES1—Phase I biotransformations, non P450—PON1—Alzheimer's disease	0.00604	0.192	CbGpPWpGaD
Ciclesonide—Osteoporosis—Donepezil—Alzheimer's disease	0.00284	0.0185	CcSEcCtD
Ciclesonide—Fracture—Donepezil—Alzheimer's disease	0.00274	0.0179	CcSEcCtD
Ciclesonide—Multiple fractures—Donepezil—Alzheimer's disease	0.00274	0.0179	CcSEcCtD
Ciclesonide—Osteoporosis—Memantine—Alzheimer's disease	0.00258	0.0168	CcSEcCtD
Ciclesonide—Osteoporosis—Rivastigmine—Alzheimer's disease	0.00252	0.0165	CcSEcCtD
Ciclesonide—Multiple fractures—Memantine—Alzheimer's disease	0.00249	0.0162	CcSEcCtD
Ciclesonide—Fracture—Memantine—Alzheimer's disease	0.00249	0.0162	CcSEcCtD
Ciclesonide—Fracture—Rivastigmine—Alzheimer's disease	0.00243	0.0159	CcSEcCtD
Ciclesonide—Multiple fractures—Rivastigmine—Alzheimer's disease	0.00243	0.0159	CcSEcCtD
Ciclesonide—Cataract—Galantamine—Alzheimer's disease	0.00216	0.0141	CcSEcCtD
Ciclesonide—CES1—Irinotecan Pathway—BCHE—Alzheimer's disease	0.00184	0.0583	CbGpPWpGaD
Ciclesonide—Contusion—Donepezil—Alzheimer's disease	0.00182	0.0119	CcSEcCtD
Ciclesonide—Gamma-glutamyltransferase increased—Memantine—Alzheimer's disease	0.00176	0.0115	CcSEcCtD
Ciclesonide—Oropharyngeal pain—Donepezil—Alzheimer's disease	0.00175	0.0114	CcSEcCtD
Ciclesonide—Dysphonia—Rivastigmine—Alzheimer's disease	0.00172	0.0112	CcSEcCtD
Ciclesonide—Gastroenteritis—Galantamine—Alzheimer's disease	0.00168	0.011	CcSEcCtD
Ciclesonide—Cataract—Donepezil—Alzheimer's disease	0.00167	0.0109	CcSEcCtD
Ciclesonide—Wheezing—Donepezil—Alzheimer's disease	0.00155	0.0101	CcSEcCtD
Ciclesonide—Cataract—Memantine—Alzheimer's disease	0.00152	0.00991	CcSEcCtD
Ciclesonide—Pain in extremity—Galantamine—Alzheimer's disease	0.00149	0.00973	CcSEcCtD
Ciclesonide—Cataract—Rivastigmine—Alzheimer's disease	0.00148	0.0097	CcSEcCtD
Ciclesonide—Candida infection—Memantine—Alzheimer's disease	0.00138	0.00901	CcSEcCtD
Ciclesonide—Ear pain—Donepezil—Alzheimer's disease	0.00135	0.00884	CcSEcCtD
Ciclesonide—Candida infection—Rivastigmine—Alzheimer's disease	0.00135	0.00881	CcSEcCtD
Ciclesonide—Diabetes mellitus—Donepezil—Alzheimer's disease	0.00133	0.00867	CcSEcCtD
Ciclesonide—Gastroenteritis—Donepezil—Alzheimer's disease	0.0013	0.00851	CcSEcCtD
Ciclesonide—Bronchitis—Galantamine—Alzheimer's disease	0.00124	0.00809	CcSEcCtD
Ciclesonide—Ear pain—Memantine—Alzheimer's disease	0.00123	0.00803	CcSEcCtD
Ciclesonide—Diabetes mellitus—Memantine—Alzheimer's disease	0.00121	0.00787	CcSEcCtD
Ciclesonide—Ear pain—Rivastigmine—Alzheimer's disease	0.0012	0.00785	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.0012	0.00782	CcSEcCtD
Ciclesonide—Gastroenteritis—Memantine—Alzheimer's disease	0.00118	0.00773	CcSEcCtD
Ciclesonide—Diabetes mellitus—Rivastigmine—Alzheimer's disease	0.00118	0.0077	CcSEcCtD
Ciclesonide—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.00116	0.00756	CcSEcCtD
Ciclesonide—Pneumonia—Galantamine—Alzheimer's disease	0.00116	0.00755	CcSEcCtD
Ciclesonide—Urinary tract infection—Galantamine—Alzheimer's disease	0.00112	0.00729	CcSEcCtD
Ciclesonide—Face oedema—Donepezil—Alzheimer's disease	0.00112	0.00728	CcSEcCtD
Ciclesonide—Epistaxis—Galantamine—Alzheimer's disease	0.00108	0.00708	CcSEcCtD
Ciclesonide—Pain in extremity—Memantine—Alzheimer's disease	0.00105	0.00685	CcSEcCtD
Ciclesonide—Haemoglobin—Galantamine—Alzheimer's disease	0.00104	0.00677	CcSEcCtD
Ciclesonide—Rhinitis—Galantamine—Alzheimer's disease	0.00103	0.00675	CcSEcCtD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR6—Alzheimer's disease	0.00103	0.0328	CbGpPWpGaD
Ciclesonide—Nasopharyngitis—Donepezil—Alzheimer's disease	0.00103	0.00675	CcSEcCtD
Ciclesonide—Haemorrhage—Galantamine—Alzheimer's disease	0.00103	0.00673	CcSEcCtD
Ciclesonide—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00103	0.0067	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.00102	0.00665	CcSEcCtD
Ciclesonide—Influenza—Donepezil—Alzheimer's disease	0.000998	0.00652	CcSEcCtD
Ciclesonide—Face oedema—Rivastigmine—Alzheimer's disease	0.000991	0.00647	CcSEcCtD
Ciclesonide—Bronchitis—Donepezil—Alzheimer's disease	0.00096	0.00627	CcSEcCtD
Ciclesonide—Nasopharyngitis—Memantine—Alzheimer's disease	0.000938	0.00613	CcSEcCtD
Ciclesonide—Immune system disorder—Galantamine—Alzheimer's disease	0.000931	0.00608	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000925	0.00604	CcSEcCtD
Ciclesonide—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000918	0.00599	CcSEcCtD
Ciclesonide—Weight increased—Donepezil—Alzheimer's disease	0.000909	0.00593	CcSEcCtD
Ciclesonide—Influenza—Memantine—Alzheimer's disease	0.000907	0.00592	CcSEcCtD
Ciclesonide—Pneumonia—Donepezil—Alzheimer's disease	0.000895	0.00585	CcSEcCtD
Ciclesonide—Bronchospasm—Memantine—Alzheimer's disease	0.000892	0.00582	CcSEcCtD
Ciclesonide—Infestation NOS—Donepezil—Alzheimer's disease	0.00089	0.00581	CcSEcCtD
Ciclesonide—Infestation—Donepezil—Alzheimer's disease	0.00089	0.00581	CcSEcCtD
Ciclesonide—Dysgeusia—Galantamine—Alzheimer's disease	0.000879	0.00574	CcSEcCtD
Ciclesonide—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000872	0.0057	CcSEcCtD
Ciclesonide—Bronchitis—Memantine—Alzheimer's disease	0.000872	0.00569	CcSEcCtD
Ciclesonide—Back pain—Galantamine—Alzheimer's disease	0.000868	0.00567	CcSEcCtD
Ciclesonide—Conjunctivitis—Donepezil—Alzheimer's disease	0.000865	0.00565	CcSEcCtD
Ciclesonide—Urinary tract infection—Donepezil—Alzheimer's disease	0.000865	0.00565	CcSEcCtD
Ciclesonide—CES1—Fluoropyrimidine Activity—SMUG1—Alzheimer's disease	0.000855	0.0271	CbGpPWpGaD
Ciclesonide—CES1—E2F transcription factor network—TP73—Alzheimer's disease	0.000853	0.0271	CbGpPWpGaD
Ciclesonide—Bronchitis—Rivastigmine—Alzheimer's disease	0.000853	0.00557	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000843	0.0055	CcSEcCtD
Ciclesonide—Epistaxis—Donepezil—Alzheimer's disease	0.00084	0.00548	CcSEcCtD
Ciclesonide—Weight increased—Memantine—Alzheimer's disease	0.000825	0.00539	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000824	0.00538	CcSEcCtD
Ciclesonide—Pneumonia—Memantine—Alzheimer's disease	0.000813	0.00531	CcSEcCtD
Ciclesonide—Infestation NOS—Memantine—Alzheimer's disease	0.000808	0.00528	CcSEcCtD
Ciclesonide—Infestation—Memantine—Alzheimer's disease	0.000808	0.00528	CcSEcCtD
Ciclesonide—Weight increased—Rivastigmine—Alzheimer's disease	0.000807	0.00527	CcSEcCtD
Ciclesonide—Haemoglobin—Donepezil—Alzheimer's disease	0.000803	0.00525	CcSEcCtD
Ciclesonide—Rhinitis—Donepezil—Alzheimer's disease	0.000801	0.00523	CcSEcCtD
Ciclesonide—Haemorrhage—Donepezil—Alzheimer's disease	0.000799	0.00522	CcSEcCtD
Ciclesonide—Pneumonia—Rivastigmine—Alzheimer's disease	0.000795	0.00519	CcSEcCtD
Ciclesonide—Palpitations—Galantamine—Alzheimer's disease	0.000793	0.00518	CcSEcCtD
Ciclesonide—Pharyngitis—Donepezil—Alzheimer's disease	0.000793	0.00518	CcSEcCtD
Ciclesonide—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000791	0.00516	CcSEcCtD
Ciclesonide—Infestation—Rivastigmine—Alzheimer's disease	0.000791	0.00516	CcSEcCtD
Ciclesonide—Urinary tract infection—Memantine—Alzheimer's disease	0.000786	0.00513	CcSEcCtD
Ciclesonide—Conjunctivitis—Memantine—Alzheimer's disease	0.000786	0.00513	CcSEcCtD
Ciclesonide—Cough—Galantamine—Alzheimer's disease	0.000783	0.00512	CcSEcCtD
Ciclesonide—Hypertension—Galantamine—Alzheimer's disease	0.000775	0.00506	CcSEcCtD
Ciclesonide—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000769	0.00502	CcSEcCtD
Ciclesonide—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000769	0.00502	CcSEcCtD
Ciclesonide—Arthralgia—Galantamine—Alzheimer's disease	0.000764	0.00499	CcSEcCtD
Ciclesonide—Chest pain—Galantamine—Alzheimer's disease	0.000764	0.00499	CcSEcCtD
Ciclesonide—Epistaxis—Memantine—Alzheimer's disease	0.000762	0.00498	CcSEcCtD
Ciclesonide—Sinusitis—Memantine—Alzheimer's disease	0.000758	0.00495	CcSEcCtD
Ciclesonide—Dry mouth—Galantamine—Alzheimer's disease	0.000747	0.00488	CcSEcCtD
Ciclesonide—Epistaxis—Rivastigmine—Alzheimer's disease	0.000746	0.00487	CcSEcCtD
Ciclesonide—Sinusitis—Rivastigmine—Alzheimer's disease	0.000742	0.00484	CcSEcCtD
Ciclesonide—Haemoglobin—Memantine—Alzheimer's disease	0.000729	0.00476	CcSEcCtD
Ciclesonide—Rhinitis—Memantine—Alzheimer's disease	0.000727	0.00475	CcSEcCtD
Ciclesonide—Haemorrhage—Memantine—Alzheimer's disease	0.000726	0.00474	CcSEcCtD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TTR—Alzheimer's disease	0.000724	0.023	CbGpPWpGaD
Ciclesonide—Pharyngitis—Memantine—Alzheimer's disease	0.00072	0.0047	CcSEcCtD
Ciclesonide—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000713	0.00466	CcSEcCtD
Ciclesonide—Rhinitis—Rivastigmine—Alzheimer's disease	0.000712	0.00465	CcSEcCtD
Ciclesonide—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00071	0.00464	CcSEcCtD
Ciclesonide—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000705	0.0046	CcSEcCtD
Ciclesonide—Dysgeusia—Donepezil—Alzheimer's disease	0.000681	0.00445	CcSEcCtD
Ciclesonide—Back pain—Donepezil—Alzheimer's disease	0.000673	0.00439	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000667	0.00436	CcSEcCtD
Ciclesonide—Immune system disorder—Memantine—Alzheimer's disease	0.000655	0.00428	CcSEcCtD
Ciclesonide—Mediastinal disorder—Memantine—Alzheimer's disease	0.000654	0.00427	CcSEcCtD
Ciclesonide—Dyspepsia—Galantamine—Alzheimer's disease	0.000645	0.00421	CcSEcCtD
Ciclesonide—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00064	0.00418	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000632	0.00413	CcSEcCtD
Ciclesonide—Fatigue—Galantamine—Alzheimer's disease	0.000632	0.00412	CcSEcCtD
Ciclesonide—Dysgeusia—Memantine—Alzheimer's disease	0.000619	0.00404	CcSEcCtD
Ciclesonide—Back pain—Memantine—Alzheimer's disease	0.000611	0.00399	CcSEcCtD
Ciclesonide—Cough—Donepezil—Alzheimer's disease	0.000607	0.00396	CcSEcCtD
Ciclesonide—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000605	0.00395	CcSEcCtD
Ciclesonide—Hypertension—Donepezil—Alzheimer's disease	0.000601	0.00392	CcSEcCtD
Ciclesonide—Back pain—Rivastigmine—Alzheimer's disease	0.000598	0.0039	CcSEcCtD
Ciclesonide—CES1—Fluoropyrimidine Activity—MTHFR—Alzheimer's disease	0.000598	0.019	CbGpPWpGaD
Ciclesonide—Arthralgia—Donepezil—Alzheimer's disease	0.000592	0.00387	CcSEcCtD
Ciclesonide—Chest pain—Donepezil—Alzheimer's disease	0.000592	0.00387	CcSEcCtD
Ciclesonide—Dry mouth—Donepezil—Alzheimer's disease	0.000579	0.00378	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—CELF1—Alzheimer's disease	0.000579	0.0184	CbGpPWpGaD
Ciclesonide—Infection—Donepezil—Alzheimer's disease	0.000564	0.00368	CcSEcCtD
Ciclesonide—Palpitations—Memantine—Alzheimer's disease	0.000558	0.00365	CcSEcCtD
Ciclesonide—Cough—Memantine—Alzheimer's disease	0.000551	0.0036	CcSEcCtD
Ciclesonide—Palpitations—Rivastigmine—Alzheimer's disease	0.000546	0.00357	CcSEcCtD
Ciclesonide—Hypertension—Memantine—Alzheimer's disease	0.000545	0.00356	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—PPP5C—Alzheimer's disease	0.000539	0.0171	CbGpPWpGaD
Ciclesonide—Cough—Rivastigmine—Alzheimer's disease	0.000539	0.00352	CcSEcCtD
Ciclesonide—Arthralgia—Memantine—Alzheimer's disease	0.000538	0.00351	CcSEcCtD
Ciclesonide—Chest pain—Memantine—Alzheimer's disease	0.000538	0.00351	CcSEcCtD
Ciclesonide—Hypertension—Rivastigmine—Alzheimer's disease	0.000534	0.00348	CcSEcCtD
Ciclesonide—Arthralgia—Rivastigmine—Alzheimer's disease	0.000526	0.00344	CcSEcCtD
Ciclesonide—Chest pain—Rivastigmine—Alzheimer's disease	0.000526	0.00344	CcSEcCtD
Ciclesonide—Dry mouth—Memantine—Alzheimer's disease	0.000526	0.00343	CcSEcCtD
Ciclesonide—Asthenia—Galantamine—Alzheimer's disease	0.000526	0.00343	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000517	0.00338	CcSEcCtD
Ciclesonide—Dry mouth—Rivastigmine—Alzheimer's disease	0.000515	0.00336	CcSEcCtD
Ciclesonide—Infection—Memantine—Alzheimer's disease	0.000512	0.00334	CcSEcCtD
Ciclesonide—Dyspnoea—Donepezil—Alzheimer's disease	0.000506	0.00331	CcSEcCtD
Ciclesonide—Infection—Rivastigmine—Alzheimer's disease	0.000501	0.00327	CcSEcCtD
Ciclesonide—Dyspepsia—Donepezil—Alzheimer's disease	0.0005	0.00326	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00049	0.0032	CcSEcCtD
Ciclesonide—Fatigue—Donepezil—Alzheimer's disease	0.00049	0.0032	CcSEcCtD
Ciclesonide—Dizziness—Galantamine—Alzheimer's disease	0.000484	0.00316	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00047	0.00307	CcSEcCtD
Ciclesonide—Rash—Galantamine—Alzheimer's disease	0.000462	0.00302	CcSEcCtD
Ciclesonide—Dermatitis—Galantamine—Alzheimer's disease	0.000461	0.00301	CcSEcCtD
Ciclesonide—Dyspnoea—Memantine—Alzheimer's disease	0.00046	0.003	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000459	0.003	CcSEcCtD
Ciclesonide—Headache—Galantamine—Alzheimer's disease	0.000459	0.003	CcSEcCtD
Ciclesonide—Dyspepsia—Memantine—Alzheimer's disease	0.000454	0.00296	CcSEcCtD
Ciclesonide—Urticaria—Donepezil—Alzheimer's disease	0.000451	0.00295	CcSEcCtD
Ciclesonide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00045	0.00294	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000445	0.00291	CcSEcCtD
Ciclesonide—Fatigue—Memantine—Alzheimer's disease	0.000444	0.0029	CcSEcCtD
Ciclesonide—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000444	0.0029	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000435	0.00284	CcSEcCtD
Ciclesonide—Nausea—Galantamine—Alzheimer's disease	0.000435	0.00284	CcSEcCtD
Ciclesonide—Fatigue—Rivastigmine—Alzheimer's disease	0.000435	0.00284	CcSEcCtD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—MAP2—Alzheimer's disease	0.000424	0.0135	CbGpPWpGaD
Ciclesonide—Urticaria—Memantine—Alzheimer's disease	0.00041	0.00267	CcSEcCtD
Ciclesonide—Asthenia—Donepezil—Alzheimer's disease	0.000407	0.00266	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—Alzheimer's disease	0.000402	0.0128	CbGpPWpGaD
Ciclesonide—Urticaria—Rivastigmine—Alzheimer's disease	0.000401	0.00262	CcSEcCtD
Ciclesonide—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.0004	0.0127	CbGpPWpGaD
Ciclesonide—Dizziness—Donepezil—Alzheimer's disease	0.000375	0.00245	CcSEcCtD
Ciclesonide—Asthenia—Memantine—Alzheimer's disease	0.00037	0.00242	CcSEcCtD
Ciclesonide—Asthenia—Rivastigmine—Alzheimer's disease	0.000362	0.00236	CcSEcCtD
Ciclesonide—Rash—Donepezil—Alzheimer's disease	0.000358	0.00234	CcSEcCtD
Ciclesonide—Dermatitis—Donepezil—Alzheimer's disease	0.000358	0.00234	CcSEcCtD
Ciclesonide—Headache—Donepezil—Alzheimer's disease	0.000356	0.00232	CcSEcCtD
Ciclesonide—Dizziness—Memantine—Alzheimer's disease	0.000341	0.00223	CcSEcCtD
Ciclesonide—Nausea—Donepezil—Alzheimer's disease	0.000337	0.0022	CcSEcCtD
Ciclesonide—Dizziness—Rivastigmine—Alzheimer's disease	0.000333	0.00218	CcSEcCtD
Ciclesonide—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000333	0.0106	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CDK5—Alzheimer's disease	0.000333	0.0106	CbGpPWpGaD
Ciclesonide—Rash—Memantine—Alzheimer's disease	0.000325	0.00212	CcSEcCtD
Ciclesonide—Dermatitis—Memantine—Alzheimer's disease	0.000325	0.00212	CcSEcCtD
Ciclesonide—Headache—Memantine—Alzheimer's disease	0.000323	0.00211	CcSEcCtD
Ciclesonide—Rash—Rivastigmine—Alzheimer's disease	0.000318	0.00208	CcSEcCtD
Ciclesonide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000318	0.00207	CcSEcCtD
Ciclesonide—Headache—Rivastigmine—Alzheimer's disease	0.000316	0.00206	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—Alzheimer's disease	0.000307	0.00974	CbGpPWpGaD
Ciclesonide—Nausea—Memantine—Alzheimer's disease	0.000306	0.002	CcSEcCtD
Ciclesonide—Nausea—Rivastigmine—Alzheimer's disease	0.0003	0.00196	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—PLAU—Alzheimer's disease	0.000299	0.0095	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—SLC6A4—Alzheimer's disease	0.000297	0.00943	CbGpPWpGaD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—Alzheimer's disease	0.000296	0.00941	CbGpPWpGaD
Ciclesonide—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000287	0.00912	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000275	0.00874	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000272	0.00862	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—Alzheimer's disease	0.000267	0.00848	CbGpPWpGaD
Ciclesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—Alzheimer's disease	0.000265	0.00842	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—CREB1—Alzheimer's disease	0.000263	0.00837	CbGpPWpGaD
Ciclesonide—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000242	0.00769	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—ACHE—Alzheimer's disease	0.000238	0.00754	CbGpPWpGaD
Ciclesonide—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—Alzheimer's disease	0.000234	0.00744	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000231	0.00734	CbGpPWpGaD
Ciclesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.00023	0.00729	CbGpPWpGaD
Ciclesonide—CES1—Fluoropyrimidine Activity—TP53—Alzheimer's disease	0.000227	0.00721	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000223	0.00708	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—HMOX1—Alzheimer's disease	0.000221	0.00701	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.000218	0.00692	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—APP—Alzheimer's disease	0.000207	0.00656	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—AGER—Alzheimer's disease	0.000198	0.0063	CbGpPWpGaD
Ciclesonide—NR3C1—Circadian Clock—PPARGC1A—Alzheimer's disease	0.000193	0.00613	CbGpPWpGaD
Ciclesonide—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000192	0.0061	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptors—ESR1—Alzheimer's disease	0.000189	0.00601	CbGpPWpGaD
Ciclesonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—Alzheimer's disease	0.000189	0.00601	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.000185	0.00588	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.000185	0.00588	CbGpPWpGaD
Ciclesonide—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000185	0.00587	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.00018	0.00571	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000179	0.0057	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Alzheimer's disease	0.000179	0.00569	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000178	0.00564	CbGpPWpGaD
Ciclesonide—NR3C1—Circadian Clock—MEF2C—Alzheimer's disease	0.000174	0.00553	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptors—PPARG—Alzheimer's disease	0.000173	0.00548	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—Alzheimer's disease	0.000166	0.00528	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000157	0.005	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—Alzheimer's disease	0.000151	0.00481	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Alzheimer's disease	0.00015	0.00478	CbGpPWpGaD
Ciclesonide—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.00015	0.00475	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.000149	0.00475	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000148	0.0047	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000146	0.00463	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000145	0.00462	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—Alzheimer's disease	0.000142	0.00451	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.000136	0.00433	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000133	0.00423	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000133	0.00422	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000133	0.00422	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.000131	0.00417	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.000128	0.00406	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—BAX—Alzheimer's disease	0.000127	0.00403	CbGpPWpGaD
Ciclesonide—NR3C1—Circadian Clock—CREB1—Alzheimer's disease	0.000127	0.00402	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—CALM1—Alzheimer's disease	0.000125	0.00397	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—APOE—Alzheimer's disease	0.000124	0.00395	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—PLAU—Alzheimer's disease	0.000123	0.00391	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000121	0.00383	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000119	0.00379	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP46A1—Alzheimer's disease	0.000118	0.00376	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000117	0.00371	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—ESR1—Alzheimer's disease	0.000116	0.00368	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—NOTCH1—Alzheimer's disease	0.000115	0.00364	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—Alzheimer's disease	0.000114	0.00364	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000112	0.00356	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000109	0.00347	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000109	0.00347	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000109	0.00346	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	0.000108	0.00342	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CREB1—Alzheimer's disease	0.000104	0.00331	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.000103	0.00328	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CCL2—Alzheimer's disease	0.000102	0.00324	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000101	0.0032	CbGpPWpGaD
Ciclesonide—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	9.86e-05	0.00313	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—PPARGC1A—Alzheimer's disease	9.7e-05	0.00308	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	9.29e-05	0.00295	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—Alzheimer's disease	9.27e-05	0.00294	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CREB1—Alzheimer's disease	9.2e-05	0.00292	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	8.87e-05	0.00282	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—LPL—Alzheimer's disease	8.83e-05	0.00281	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—MEF2C—Alzheimer's disease	8.76e-05	0.00278	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	8.7e-05	0.00276	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—TGFB1—Alzheimer's disease	8.39e-05	0.00266	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	8.39e-05	0.00266	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	8.15e-05	0.00259	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	7.98e-05	0.00253	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	7.87e-05	0.0025	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	7.82e-05	0.00248	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	7.75e-05	0.00246	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	7.64e-05	0.00243	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	7.57e-05	0.0024	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—LEP—Alzheimer's disease	7.41e-05	0.00235	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	7.23e-05	0.0023	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—MAOB—Alzheimer's disease	7.07e-05	0.00225	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	6.88e-05	0.00219	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	6.59e-05	0.00209	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PHF1—Alzheimer's disease	6.56e-05	0.00208	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	6.47e-05	0.00205	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—PPARG—Alzheimer's disease	6.45e-05	0.00205	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—CREB1—Alzheimer's disease	6.36e-05	0.00202	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—INS—Alzheimer's disease	6.33e-05	0.00201	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Alzheimer's disease	6.26e-05	0.00199	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	6.24e-05	0.00198	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—TGFB1—Alzheimer's disease	6.16e-05	0.00196	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IGF1—Alzheimer's disease	6.12e-05	0.00194	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	6.07e-05	0.00193	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	6.02e-05	0.00191	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	5.5e-05	0.00175	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	5.36e-05	0.0017	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TP53—Alzheimer's disease	4.96e-05	0.00157	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	4.62e-05	0.00147	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL6—Alzheimer's disease	4.54e-05	0.00144	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—Alzheimer's disease	4.37e-05	0.00139	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—TFAM—Alzheimer's disease	4.23e-05	0.00134	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	4.08e-05	0.0013	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	4.07e-05	0.00129	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—Alzheimer's disease	4e-05	0.00127	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	3.72e-05	0.00118	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—Alzheimer's disease	3.69e-05	0.00117	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TGFB1—Alzheimer's disease	3.67e-05	0.00116	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	3.5e-05	0.00111	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	3.45e-05	0.0011	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	3.44e-05	0.00109	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TNF—Alzheimer's disease	3.43e-05	0.00109	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.39e-05	0.00108	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	3.04e-05	0.000964	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	2.96e-05	0.00094	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6—Alzheimer's disease	2.76e-05	0.000878	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CA4—Alzheimer's disease	2.58e-05	0.00082	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	2.58e-05	0.00082	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	2.55e-05	0.000808	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	2.5e-05	0.000792	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	2.43e-05	0.000771	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.39e-05	0.000759	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	2.36e-05	0.000748	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	2.3e-05	0.000731	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLD3—Alzheimer's disease	2.2e-05	0.000697	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	2.11e-05	0.000668	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	2.03e-05	0.000643	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.99e-05	0.000631	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.96e-05	0.000621	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.69e-05	0.000536	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.59e-05	0.000504	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.5e-05	0.000478	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.44e-05	0.000456	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.38e-05	0.000437	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.32e-05	0.000421	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.28e-05	0.000406	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.26e-05	0.0004	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.26e-05	0.0004	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ESR1—Alzheimer's disease	1.24e-05	0.000395	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.21e-05	0.000384	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	1.2e-05	0.000382	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.16e-05	0.00037	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PPARG—Alzheimer's disease	1.13e-05	0.00036	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.12e-05	0.000357	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ACHE—Alzheimer's disease	9.78e-06	0.000311	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	9.67e-06	0.000307	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	9.16e-06	0.000291	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ENO1—Alzheimer's disease	9.16e-06	0.000291	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—BCHE—Alzheimer's disease	8.52e-06	0.000271	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TPI1—Alzheimer's disease	8.25e-06	0.000262	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CHAT—Alzheimer's disease	8.25e-06	0.000262	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	8.04e-06	0.000255	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MAOB—Alzheimer's disease	7.9e-06	0.000251	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	7.79e-06	0.000247	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	7.61e-06	0.000242	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—A2M—Alzheimer's disease	7.35e-06	0.000233	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	6.72e-06	0.000213	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	6.68e-06	0.000212	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ACHE—Alzheimer's disease	6.39e-06	0.000203	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	6.32e-06	0.000201	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LPL—Alzheimer's disease	6.11e-06	0.000194	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.99e-06	0.00019	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.99e-06	0.00019	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.87e-06	0.000187	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—BCHE—Alzheimer's disease	5.57e-06	0.000177	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	5.5e-06	0.000175	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	5.26e-06	0.000167	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CALM1—Alzheimer's disease	5.14e-06	0.000163	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOE—Alzheimer's disease	5.12e-06	0.000163	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	5.09e-06	0.000162	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CAV1—Alzheimer's disease	5.08e-06	0.000161	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AKT1—Alzheimer's disease	4.48e-06	0.000142	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPARG—Alzheimer's disease	4.46e-06	0.000142	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.39e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—INS—Alzheimer's disease	4.38e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.37e-06	0.000139	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LPL—Alzheimer's disease	4e-06	0.000127	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.84e-06	0.000122	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.6e-06	0.000114	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3.51e-06	0.000112	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.36e-06	0.000107	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.35e-06	0.000106	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.32e-06	0.000105	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.92e-06	9.27e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—INS—Alzheimer's disease	2.86e-06	9.09e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.51e-06	7.97e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.3e-06	7.29e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.76e-06	5.6e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.15e-06	3.66e-05	CbGpPWpGaD
